Hormonal and immunologic methods in the diagnosis and treatment of patients with benign ovarian tumors and endometriotic cysts.
This study evaluated hormonal and immunologic markers in patients with endometriotic cysts and benign ovarian tumors, finding elevated LH and abnormal receptor levels in endometriosis, suggesting hormone therapy for endometriotic cysts.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (7)
- Non-invasive diagnosis of endometriosis: Immunologic and genetic markers 2022
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Combination of the non-invasive tests for the diagnosis of endometriosis 2016
- Endometrial biomarkers for the non-invasive diagnosis of endometriosis 2016
- Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta‐analysis 2016
- An investigation of the surgical treatment of endometriosis 2010
- Peripheral biomarkers of endometriosis: a systematic review 2010
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:11:39.448046+00:00